Myron Kaplan, Director at CorMedix Inc. (CRMD), bought 5,000 shares at $3.78 ($19K) on 2022-05-17, disclosed to the SEC on 2022-05-18.
Open-market purchase of $19k CRMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| CRMD | BUY | 2021-11-19 | $51K | — | Filing → |
| CRMD | BUY | 2021-05-19 | $90K | — | Filing → |
| CRMD | BUY | 2020-09-04 | $131K | — | Filing → |